Biogen Inc. buy Wells Fargo & Company
Start price
09.11.23
/
50%
€210.20
Target price
09.11.24
€340.62
Performance (%)
-22.79%
End price
10.11.24
€162.30
Summary
This prediction ended on 10.11.24 with a price of €162.30. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.79%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -0.251% | -0.251% | 24.150% |
| iShares Core DAX® | -1.104% | -6.084% | 0.866% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 18.263% |
| iShares Nikkei 225® | -1.082% | -7.987% | 26.339% |
| iShares S&P 500 | -0.055% | 0.880% | 13.287% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Wells Fargo & Company from $343.00 to $365.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten